What is your approach for treating transplant-ineligible patients with relapsed blastic plasmacytoid dendritic cell neoplasm (BPDCN) who have progressed on tagraxofusp?  


Answer from: Medical Oncologist at Community Practice
Comments
at Memorial Hospital for Cancer & Allied Diseases
Agree with Dr. @David Rizzieri. If they are a cand...
Sign in or Register to read more